7 completed. 7 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 7 |
Follow Pediatrics: new trials by email Literature Review of Pediatrics trials Research Report on Pediatrics
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Norepinephrine for Prevention of Intraoperative Hypotension in Infants Undergoing Kasai Portoenterostomy Norepinephrine Bitartrate, Placebo - Anesthesia, Pediatrics | Phase 3 | Completed | Kasr El Aini Hospital | 31 | 2022-08-28 | 2024-07-09 |
| The Hemodynamic Effects of Different Volumes of Bupivacaine 0.25% Caudal Blocks in Pediatrics Undergoing Lower Abdominal Surgeries as Measured by Electrical Cardiometry Bupivacaine Hydrochloride - Anesthesia, Caudal, Pediatrics | Phase 3 | Completed | Kasr El Aini Hospital | 105 | 2021-11-15 | 2024-07-09 |
| BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity Botulinum Toxin Type A - Pediatrics, Muscle Spasticity | Phase 3 | Completed | Allergan | 370 | 2012-11-05 | 2019-08-21 |
| BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity Botulinum Toxin Type A - Pediatrics, Muscle Spasticity | Phase 3 | Completed | Allergan | 220 | 2012-10-30 | 2019-08-21 |
| BOTOX® Treatment in Pediatric Lower Limb Spasticity botulinum toxin Type A, Normal Saline (Placebo) - Pediatrics, Muscle Spasticity | Phase 3 | Completed | Allergan | 384 | 2012-09-11 | 2018-08-14 |
| BOTOX® Treatment in Pediatric Upper Limb Spasticity botulinum toxin Type A, Normal Saline (Placebo) - Pediatrics, Muscle Spasticity | Phase 3 | Completed | Allergan | 235 | 2012-07-12 | 2018-08-14 |
| Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children Dexmedetomidine, Saline - Agitation, Anesthesia | Phase 3 | Completed | St. Luke's-Roosevelt Hospital Center | 33 | 2009-08-01 | 2018-11-27 |
Cerebral Palsy (4) · Muscle Spasticity (4) · Stroke (2) · Biliary Atresia (1) · Emergence Delirium (1) · Hypotension (1) · Psychomotor Agitation (1)
Nervous System Diseases (5) · Neurologic Manifestations (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Brain Damage, Chronic (4) · Brain Diseases (4) · Central Nervous System Diseases (4) · Muscle Hypertonia (4) · Muscular Diseases (4) · Musculoskeletal Diseases (4) · Neuromuscular Manifestations (4) · Cardiovascular Diseases (3) · Vascular Diseases (3) · Cerebrovascular Disorders (2) · Aberrant Motor Behavior in Dementia (1)
Botulinum Toxins, Type A (4) · Saline Solution (2) · Bupivacaine (1) · Dexmedetomidine (1) · Norepinephrine (1) · Sodium Chloride (1)
Allergan (4) · Kasr El Aini Hospital (2) · St. Luke's-Roosevelt Hospital Center (1)
United States (5) · Hungary (4) · Philippines (4) · Poland (4) · Russia (4) · South Korea (4) · Thailand (4) · Turkey (Türkiye) (4) · Canada (2) · Egypt (2) · Italy (2)
Emily McCusker (2) · Rozalina Dimitrova (2) · Jolie Narang, M.D. (1) · Khaled Sarhan, MD (1)